Search on Site

Explore our comprehensive database of pharmaceutical news releases, press releases, events, and industry insights with ease. Effortlessly find relevant information tailored to your interests and stay updated on the latest developments in the pharmaceutical sector. Start searching now to uncover valuable insights and resources for your pharmaceutical endeavors.

UPSHER-SMITH LAUNCHES METHIMAZOLE TABLETS, USP

Listed Drug (RLD) was the brand Tapazole®*. About Upsher-Smith: Upsher-Smith Laboratories, LLC is a trusted U.S. pharmaceutical company that strives to improve the health and lives of patients through an unwavering commitment to high-quality...

Neurocrine Biosciences begins Phase 1 trial on NBI-1065890, a second-gen VMAT2 inhibitor, in healthy adults

Huntington's disease. About Neurocrine Biosciences : Neurocrine Biosciences is a leading neuroscience-focused, biopharmaceutical company with a simple purpose: to relieve suffering for people with great needs, but few options. We are dedicated to...

Brainomix's AI-Powered e-Lung, Developed with AstraZeneca, Improves Identification of Lung Fibrosis Patients at Risk

and Critical Care Medicine (AJRCCM)1, resulting from a research collaboration AstraZeneca, the UK's leading Biopharmaceutical company. The results showed that Brainomix e-Lung, an AI-enabled automated CT processing software, stratifies patients at...

Akebia's Vafseo® (vadadustat) Tablets FDA Approved for Anemia Treatment in Dialysis Patients

Akebia Therapeutics®, Inc. (Nasdaq: AKBA), a biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease, today announced that the U.S. Food and Drug Administration (FDA) has approved Vafseo® (vadadustat)....

Psilera Welcomes Biopharma Executive Dr. Magali Haas to its Board of Directors

pursuit of improving the lives of individuals affected by brain-related conditions. About Psilera: Psilera is a biopharmaceutical company focused on developing innovative patient-centric therapies for neurological disorders. They are the first...

Telix's TLX250-CDx: First Patient Dosed in Italian Early Access Program for Kidney Cancer Imaging

Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces that the first patient has been dosed in its named patient program in Italy for TLX250-CDx (89Zr-DFO-girentuximab, Zircaix™. TLX250-CDx is the Company's investigational...

Gedeon Richter Chooses Trial Interactive for Streamlined Clinical Trial Management

TransPerfect Life Sciences, a leading global provider of solutions for product development and launch for the biopharmaceutical industry, today announced that Gedeon Richter selected Trial Interactive's award-winning eTMF platform and TI...

Aptamer Sciences Inc.Innovative Liver Cancer Treatment AST-201

Korea. Dr. Chon remarked, "GPC3 has garnered considerable attention in liver cancer therapeutic development among biopharmaceutical companies," expressing optimism that "AST-201 may emerge as a novel treatment option for liver cancer patients."...

Translational Vision Science and Technology Journal Publishes RadiusXR's NOVA Clinical Trial

announced it entered into a collaboration and marketing agreement with Glaukos Corporation, a leading ophthalmic pharmaceutical and medical technology company, whereby Glaukos became the exclusive sales agent to market, promote, and solicit orders...

ProteoNic unveils Early Access Program, boosting viral vector titers with LV-2G UNic® technology

With the official launch on March 20, 2024, ProteoNic extends a warm invitation to CDMOs, biotechs, and biopharmaceutical companies to experience firsthand the transformative potential of LV-2G UNic®. By seamlessly integrating this cutting-edge...

Brazilian Entrepreneur Launches Entourage Phytolab on One Lavi

not only provide therapeutic benefits but also improve the overall quality of life," Abreu said. "We aim to introduce pharmaceutical-grade products that stand out for their quality and effectiveness." The Entourage Liquid Fusionner™ – Night Use...

Ginkgo Technology Network Launches, Providing an Integrated R&D

end-to-end services that solve challenges for organizations across diverse markets, from food and agriculture to pharmaceuticals to industrial and specialty chemicals. Ginkgo's biosecurity and public health unit, Concentric by Ginkgo, is building...

Improved Pharma Brings Onboard Micro-DSC Hot-Stage System

very small quantities of materials is crucial in both early stages when sample size is limited, and late stages of pharmaceutical development, when a new form may unexpectedly pop-up. " Dr. Pamela Smith, COO of Improved Pharma adds, "We are...

Tetra Pharm Technologies advances CB1 antagonist, TPT0701, for appetite suppression into preclinical testing

Officer, Tetra Pharm Technologies. About Tetra Pharm Technologies ApS: Tetra Pharm Technologies is a Danish biopharmaceutical company established in 2018 with a vision to be a leader in research and development of pharmaceutical drugs for the...

Privacy Policy | Pharmaceutical-Era.com - Protecting Your Information

Privacy Policy At Pharmaceutical-Era, we are committed to protecting your privacy. This Privacy Policy outlines how we collect, use, and disclose personal information when you use our website (www.pharmaceutical-era.com). Information We Collect:...

Terms of Use | Pharmaceutical-Era.com - Understand Our Terms and Conditions

Terms Of Use — Terms & Conditions Welcome to Pharmaceutical-Era (referred to as "Pharmaceutical-Era," "we," "us," or "our"). By accessing or using our website (www.pharmaceutical-era.com), you agree to comply with and be bound by the following...

Editorial Guidelines | Pharmaceutical-Era.com

Editorial Guidelines At Pharmaceutical-Era.com, we strive to maintain the highest standards of quality and integrity in our editorial content. Our guidelines are designed to ensure that all articles, press releases, and other submissions are...

How It Works | Pharmaceutical-Era.com - Simplifying Your Experience with Event Listings, News & Services

How Does It Work? — Explore Our Comprehensive Services and Their Benefits Pharmaceutical-Era.com is dedicated to providing top-tier press release distribution, publication services, and event promotion exclusively for the pharmaceutical industry....

FAQs

Frequently Asked Questions (FAQs) What are the genuine benefits of using Pharmaceutical-Era.com for press release distribution or promotion? Pharmaceutical-Era.com offers unparalleled visibility to your press releases within the pharmaceutical...

About Us | Pharmaceutical-Era.com - Leading B2B Media for the Pharmaceutical Industry

Your Premier Global Platform for Pharmaceutical Insights and Events Welcome to Pharmaceutical Era, your trusted partner in navigating the dynamic landscape of the worldwide pharmaceutical industry. Established in 2011 by HISS Media Pvt Ltd, an...